Article info

Download PDFPDF
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder

Authors

  • Peir-In Liang Department of Pathology, Chi-Mei Foundation Medical Center, Liouying, Tainan, Taiwan Departments of Pathology, Chi-Mei Foundation Medical Center, Tainan, Taiwan Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Yu-Hui Wang Institute of Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Ting-Feng Wu Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Wen-Ren Wu Institute of Biomedical Science, National Sun Yat-Sen University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Alex C Liao Departments of Urology, Chi-Mei Foundation Medical Center, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Kun-Hung Shen Departments of Urology, Chi-Mei Foundation Medical Center, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Chung-Hsi Hsing Departments of Anesthesiology, Chi-Mei Foundation Medical Center, Tainan, Taiwan College of Medicine, Taipei Medical University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Yow-Ling Shiue Institute of Biomedical Science, National Sun Yat-Sen University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Hsuan-Ying Huang Departments of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Han-Ping Hsu College of Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Li-Tzon Chen National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan Departments of Molecular Medicine, National Cheng Kung University, Tainan, Taiwan Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan Cancer center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Ching-Yih Lin Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chi-Mei Foundation Medical Center, Tainan, Taiwan Department of Leisure, Recreation, and Tourism Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Chein Tai Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan PubMed articlesGoogle scholar articles
  • Jui-Yu Wu College of Medicine, Taipei Medical University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Chien-Feng Li Departments of Pathology, Chi-Mei Foundation Medical Center, Tainan, Taiwan Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chien-Feng Li, Department of Pathology, Chi-Mei Medical Center, No. 901, Chunghwa Road, Yongkang Dist, Tainan City 710, Taiwan; angelo.p{at}yahoo.com.tw
View Full Text

Citation

Liang P, Wang Y, Wu T, et al
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder

Publication history

  • Received October 14, 2012
  • Revised February 22, 2013
  • Accepted February 25, 2013
  • First published March 28, 2013.
Online issue publication 
June 14, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.